logo
Mental health in the age of AI

Mental health in the age of AI

Straits Times2 days ago
Apps may be able to assist in cognitive behavioural therapy, detect depression risk in the user's voice, and more, experts here say.
SINGAPORE - It is generally a two-month wait to see a psychiatrist at the Institute of Mental Health (IMH) outpatient clinic.
So, to help patients through the dry spell between sessions, the hospital is studying if they can use a locally developed AI-powered app that, among other things, provides guided meditation and is able to predict the user's stress level.
Since May 2025, IMH has offered the AmDTx app, or a placebo app, to individuals referred by a GP or a polyclinic doctor to the institute, to participate in the trial.
'Coping skills such as deep breathing and sleep hygiene can help one manage stress, or even symptoms of anxiety and depression. They can learn these from the app and start the interventions first. This will hopefully reduce their distress while waiting to see the specialist,' said Dr Christopher Cheok, a senior consultant at IMH and director of national mindline 1771, Singapore's first helpline and text service for mental health.
Dr Cheok said the long wait times in public mental healthcare are because of rising demand and limited manpower.
IMH is also exploring the use of other apps to monitor and support the care of mental health conditions, including one approved by the United States Food and Drug Administration (FDA).
In general, digital tools include AI-enabled chatbots, mobile apps, wearable devices, and web-based programmes. Apps may be able to assist in cognitive behavioural therapy, detect depression risk in the user's voice, and more, experts here say.
Top stories
Swipe. Select. Stay informed.
Singapore Sewage shaft failure linked to sinkhole; PUB calling safety time-out on similar works islandwide
Singapore Tanjong Katong Road sinkhole did not happen overnight: Experts
Singapore Workers used nylon rope to rescue driver of car that fell into Tanjong Katong Road sinkhole
Asia Singapore-only car washes will get business licences revoked, says Johor govt
World Food airdropped into Gaza as Israel opens aid routes
Sport Arsenal beat Newcastle in five-goal thriller to bring Singapore Festival of Football to a close
Singapore Benchmark barrier: Six of her homeschooled kids had to retake the PSLE
Asia S'porean trainee doctor in Melbourne arrested for allegedly filming colleagues in toilets since 2021
Some of these tools can be seen at an exhibition on digital mental health, organised by the Yeo Boon Khim Mind Science Centre and D.S. Lee Foundation Mind Art Experiential Lab (MAELab), which opened at the MAELab space in Alexandra Hospital on July 11.
While the centre said it does not endorse any of the tools, they demonstrate the potential of digital and AI-powered technology in mental healthcare.
Tech can help
An app that is available from a healthcare provider, Rejoyn was the first prescription digital therapeutic for the treatment of major depressive disorder to be approved by the FDA, in 2024. The smartphone app, designed to be used alongside medication, delivers a programme of evidence-based brain-training exercises and therapeutic lessons to help adult patients manage their symptoms.
Other tools shown at Maelab include an online assessment tool from local firm Neurowyzr, which screens for early cognitive changes, and a Voice AI tool from another Singapore-based firm, Wonder Technologies, that screens for depression risk.
The latter will soon undergo testing over a year with participants recruited from institutions affiliated with the National University of Singapore and National University Healthcare System, said the firm's CEO, Ms Wendy Wu.
A similar Voice AI tool to detect early signs of depression in older adults is being developed here under SoundKeepers, a three-year local programme announced in October 2024. Its researchers said that developing a native technology for Singapore facilitates compliance with national healthcare data protection standards.
It was at the height of the Covid-19 pandemic in June 2020 that the MOH Office for Healthcare Transformation (MOHT) created
mindline.sg as a digital mental health resource website, which now boasts an AI-enabled chatbot Wysa.
Ms Janice Weng, deputy director of
mindline.sg at MOHT, said digital solutions are useful for mental health self-help, and the office would like to pilot a form of self-directed psychotherapy that is being used at IMH in community and primary care settings.
iCBT, internet-based Cognitive Behavioural Therapy, could enhance access to affordable mental health care in the community and help reduce unnecessary visits to the hospitals, she said.
MOHT is starting to develop AI models analysing Singlish, multilingual texts, and emotional cues and nuances that Western tools may miss, she added.
Another digital health platform that it co-developed with IMH uses data from fitness trackers and smartphones to help care teams tailor support and empower individuals with psychosis and mood disorders to manage their own mental health. It may be useful for predicting depression in youth.
Digital phenotyping, which uses smartphone data to understand user behaviour, is emerging as a promising way to detect mental health issues. Researchers have found, for example, that shifts in heart rate variability or sleep patterns can signal anxiety or low mood before individuals are even aware of it.
Dr Jill Murphy, the executive director of the APEC Digital Hub for Mental Health who was in Singapore recently, said she is particularly excited about how this technology could lead to more personalised care. 'Although more research is needed in this area, it has the potential to shift the focus from broad categories of mental illness like depression to a more patient-centred approach,' she said.
Tailoring interventions and treatment plans to match a person's unique needs, values, culture and experiences could also increase engagement with digital tools, she added. Dr Murphy was a plenary speaker at the July 16-17 Singapore Mental Health Conference, addressing how to use digital technologies to promote equitable access to mental health promotion and care in the Apec region.
Treading with caution
A big problem with digital mental health tools, however, is the sheer number of options out there, the majority of which have not been proven to be effective.
Adjunct Associate Professor Cornelia Chee, head and senior consultant at National University Hospital's psychological medicine department, said plenty of work remains to establish the effectiveness, safety, and ethical use of digital and AI-enabled tools in real-world clinical settings.
She cautioned that these tools should complement, and not replace, the therapeutic relationship that remains central to mental healthcare.
The Organisation for the Review of Care and Health Apps (Orcha), founded by clinicians from the United Kingdom's National Health Service, reviewed approximately 35,000 uses of digital health technology, and found just 20 per cent to be secure, cyber-safe, and clinically effective.
Dr Cheok said a search shows that there are more than 10,000 mental health apps on Apple and Google Play Store.
'In general, I think because apps are not regulated, no one can vouch for the quality of the information contained in the app or the intervention that's within the app, and one thing the public may not be so aware of is how their data is being used,' he said. 'Therefore, whichever apps we choose to evaluate, they must have shown to be useful in other countries and have been subjected to research studies for efficacy and validation.'
Dr Cheok said IMH picked the AmDTx app as it was shown to work overseas, and is now studying its effectiveness in the local population. The other test site for the trial, expected to end by the first quarter of 2026, is the Singapore General Hospital.
For now, Dr Murphy advises checking app privacy policies, published scientific studies, and endorsements from reputable organisations when evaluating digital mental health tools.
She said organisations like Orcha have established standards for reviewing apps. Orcha has also created a Mind App Library, where users can browse apps that meet the standards that it has identified, she said.
Associate Professor John Wong, director of the Yeo Boon Khim Mind Science Centre, said that with more apps coming to market, individuals must learn to make informed choices.
'What you really want is not to tell people what to buy, what to use, but what is in the technology, what is it that you need? And then they can be informed users,' he said.
IMH chief executive officer Daniel Fung said validated digital tools for the population will likely be accessible through mindline.sg in the future.
MOHT's Ms Weng said programmes such as
mindline.sg , iCBT, and peer-led platforms could in the future make mental healthcare widely and easily accessible.
'Singapore can pioneer a hybrid model – where AI handles scale and prevention, and limited manpower focuses on where the needs are best met with empathy and complex care,' she said.
Tracking tiny shifts in our bodies that hint at mental strain
An exhibition on digital mental health tools highlights some biomarker changes that precede mental health issues. It was launched by the Yeo Boon Khim Mind Science Centre at its MAELab space in Alexandra Hospital.
1. Depression and anxiety
Biomarkers: Reduced heart rate variability (HRV), poor sleep quality, decreased activity levels.
Insight: These changes often show days or weeks before someone reports feeling low or anxious. Wearables can detect the trend early, nudging users to seek help or adjust their lifestyles.
2. Burnout or chronic stress
Biomarkers: Elevated resting heart rate, decreased HRV, poor sleep quality.
Insight: These signs appear subtly – even before people feel stressed. Smartwatches can send alerts for persistent physiological stress.
3. Menstrual-related mood disorders
Biomarkers: Changes in sleep patterns, increased body temperature and resting heart rate.
Insight: Devices can track how your body responds across cycles and alert you to abnormal patterns, such as more severe mood changes.
Know your biomarkers
Heart rate variability
HRV – the variation in time between each heartbeat – can indicate overall stress burden and recovery status. Reduced HRV has been observed in anxiety disorders, depression, and more.
HRV is highly individual, as it is influenced by factors such as genetics, age and sex, so comparing it across individuals is often unhelpful. Longitudinal tracking of one's own HRV baseline offers more meaningful insights.
While a higher HRV is generally considered better, there is no universal cut-off for what constitutes 'low HRV'. A sustained drop of 20 per cent to 30 per cent below an individual's norm over weeks or months may be more indicative of concern than a one-off low reading.
Respiratory rate
The number of breaths you take every minute reflects how your body is functioning, especially during rest or sleep.
Changes in your respiratory rate – especially when you are asleep – can be early signs of not just issues such as infections, but also of stress or anxiety. It can also be due to overtraining or hormonal fluctuations.
Body temperature
Wearables can measure peripheral skin or wrist temperature (not core temperature).
A rise in temperature from your baseline level can signal the early stages of infection or illness while a subtle rise can indicate ovulation due to hormonal changes. Look for repeated or sustained increases from your usual pattern.
Also, a small elevation of 0.2 deg C to 0.5 deg C, for example, may not point to illness but, when combined with other symptoms, it might suggest your body is under stress.
Sleep metrics
Sleep, including its various stages, can be tracked by analysing metrics such as HRV, body temperature and more.
They help to detect sleep patterns linked not just to physical issues – such as reduced deep sleep after overtraining – but also mental health issues, such as insomnia in depression or fragmented sleep in anxiety.
A lack of sleep is associated with irritability, anxiety, and a higher risk of depression. Deep sleep regulates stress hormones while REM (rapid eye movement) sleep supports emotional processing.
Activity metrics
These include steps taken, calories burned, distance travelled and activity intensity.
Physical activity triggers endorphins, dopamine, serotonin and norepinephrine, which are key regulators of mood, motivation, and stress resilience.
Regular activity is linked to reduced stress, improved mood, better sleep, and lower rates of depression and anxiety. Tracking one's activity metrics can reinforce these positive behaviours.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Long-term care costs in ageing Singapore rise to nearly S$3,000 a month: Singlife
Long-term care costs in ageing Singapore rise to nearly S$3,000 a month: Singlife

Independent Singapore

time6 hours ago

  • Independent Singapore

Long-term care costs in ageing Singapore rise to nearly S$3,000 a month: Singlife

Photo: Depositphotos/ glowonconcept (for illustration purposes only) Personal Finance Singapore News SINGAPORE: Long-term care in Singapore has become increasingly expensive, with average monthly costs now nearing US$2,340 (S$3,000), up from US$1,813 (S$2,324) in 2018, reflecting an annual inflation rate of about 4%, Singapore Business Review reported. It cited data from a Singlife white paper titled From Awareness to Action: Securing Long-Term Care for a Super-Aged Society. The report warned that many Singaporeans are not financially ready to deal with these rising costs, especially as the country moves towards becoming a super-aged society by next year . In mid-July, a study from Manulife also reported that fewer than half of high-net-worth individuals (HNWIs) in the city-state feel they're financially prepared for long-term care and medical expenses later in life. Currently, government schemes such as ElderShield and CareShield Life provide monthly payouts of up to US$516 (S$662), which fall short of what's actually needed. The report also found that only one in three Singaporeans aged 30 and above have supplementary long-term care insurance coverage, suggesting many are still relying on their personal savings or family for support. The majority of individuals typically require long-term care for 10 years, with some cases lasting more than 15 years, according to claims data from 2010 to 2024. Meanwhile, the insurer pointed out that the youngest claimant in its records was just 32 years old. To secure long-term care for an ageing society like Singapore, Singlife recommended early detection and prevention of major illnesses, adding long-term care to retirement planning, promoting physical and mental health, strengthening community support systems, and improving public and private services coordination to address these concerns. /TISG Read also: About 6,000 vulnerable seniors to benefit from S$7.3M DBS Foundation programme, but netizens say it's just a 'band-aid measure' Featured image by Depositphotos (for illustration purposes only) () => { const trigger = if ('IntersectionObserver' in window && trigger) { const observer = new IntersectionObserver((entries, observer) => { => { if ( { lazyLoader(); // You should define lazyLoader() elsewhere or inline here // Run once } }); }, { rootMargin: '800px', threshold: 0.1 }); } else { // Fallback setTimeout(lazyLoader, 3000); } });

Coroner's court: Man, 65, died after spinal surgery, no evidence COVID-19 vaccine implicated
Coroner's court: Man, 65, died after spinal surgery, no evidence COVID-19 vaccine implicated

CNA

time11 hours ago

  • CNA

Coroner's court: Man, 65, died after spinal surgery, no evidence COVID-19 vaccine implicated

SINGAPORE: A 65-year-old man with multiple chronic conditions died after his airway was blocked following an operation on his spine. He had received the COVID-19 vaccine 10 days before the operation, but there was no evidence the vaccine caused or contributed to his death, the coroner's court heard. The vaccine issue had been raised in court by the deceased man's daughter. In findings made available on Tuesday (Jul 29), State Coroner Adam Nakhoda ruled the death of Mr Lee Yong Chuan Edwin a medical misadventure. According to the findings, Mr Lee died on May 29, 2021 at Mount Elizabeth Hospital. He had several chronic medical conditions, including depression and panic attacks, ischaemic heart disease, hypertension, coronary artery disease and pancreatic cancer. He had undergone a Whipple resection - a procedure to treat tumours and other pancreatic conditions - at Mount Elizabeth Hospital in 2009 for the cancer, and received follow-up radiotherapy and chemotherapy. WHAT HAPPENED On Apr 7, 2021, Mr Lee saw Dr Tan Seang Beng at his clinic, complaining that he had experienced numbness and paraesthesia - a tingling or prickling sensation - in his hands for a number of years. A clinical examination along with a magnetic resonance imaging (MRI) scan of his spine revealed deterioration in his spine. He was diagnosed with a pinched nerve and an injury to his spinal cord from severe compression, along with a prolapsed intervertebral disc. In May 2021, Mr Lee consented to undergo a procedure called an anterior cervical discectomy and fusion (ACDF) of his vertebrae. It was scheduled for May 6, 2021 at Mount Elizabeth Hospital. The consent form highlighted, among other things, that the procedure would involve decompressing the nerves within the spine by removing the disc, removing bone spurs and repairing and reconstructing the spine by fusion. The form also highlighted possible complications such as voice and swallowing problems, wound infection, nerve or spinal cord injury and paralysis, complications related to anaesthesia, blood transfusion reactions, heart attack and death. The consent form stated that the listed risks and complications were not intended to be exhaustive. The anaesthetist explained to Mr Lee that there was a "slightly higher risk" of anaesthesia as an airway assessment revealed that Mr Lee's neck movements were limited, in particular neck extension. Mr Lee agreed to be monitored in hospital after the surgery. The procedure was carried out on May 6, 2021. Dr Tan said it was "uneventful" and was completed. Mr Lee was stable while under general anaesthesia and was able to speak and move his limbs after waking up. He was transferred to the intensive care unit (ICU) for routine monitoring at about 8.10pm, about half an hour after the surgery was completed. However, at about 10.10pm, Mr Lee told the nurses that he could not breathe. They propped him up, increased his oxygenation and encouraged him to breathe deeply. The nurses then inserted an oral airway in an attempt to suction his airway, as they suspected there was a mucous plug, since Mr Lee said he felt something in his throat. Mr Lee spat out the oral airway and repeated that he could not breathe. Other medical personnel were called in to help, but Mr Lee's oxygen saturation dropped and he became unresponsive. A "code blue" was activated and the nurses tried to perform Ambubag ventilation - artificial respiration using a hand-held device. The staff attempted to intubate him to no avail, and his condition improved only after doctors arrived and managed to intubate him. Mr Lee's blood pressure, heart rate and oxygen saturation were later maintained with full ventilation and IV adrenaline infusion, following interventions from doctors, and he was transferred to the ICU. However, MRI scans two days later showed severe brain damage consistent with hypoxia - insufficient oxygen - which was due to the long resuscitation time. There was also bleeding behind his throat. Mr Lee was supported in the ICU until May 28, 2021, when his condition deteriorated. He died a day later. An autopsy certified his cause of death as hypoxic ischaemic encephalopathy, a type of brain complication due to lack of oxygen, following cardiac arrest. This was in turn due to airway obstruction, due to retropharyngeal haemorrhage. This is a type of rare but life-threatening condition where blood accumulates behind the pharynx in the throat. This bleeding occurred after the spinal procedure. Senior Consultant Forensic Pathologist Teo Eng Swee said Mr Lee's death was related to a post-operative complication. Airway obstruction due to acute retropharyngeal haemorrhage is a known complication after the spinal procedure in this case, said Dr Teo. EVIDENCE FROM MR LEE'S FAMILY Mr Lee's daughter said her grandfather had been admitted to hospital due to impingement of nerves that required surgery and could cause paralysis. When Mr Lee realised he might have the same condition as his father, he sought medical attention and consulted Dr Tan. Mr Lee's daughter said Dr Tan had recommended the spinal procedure, which was the same one Mr Lee's father had undergone in February 2021. Mr Lee's daughter advised him to wait before having the surgery, but Mr Lee decided to go ahead after a discussion with Dr Tan. Mr Lee's daughter said "the only risk (Mr Lee) talked about then was paralysis, a common one of spinal surgery". She added that her father had received a COVID-19 vaccination 10 days before the surgery. She raised several concerns during the inquiry. These included whether the surgical team fully considered her father's complex medical history and whether he was sufficiently advised about the risks, given his "complex medical and health status" including the COVID-19 vaccine he had received less than two weeks before the operation. At the time of the operation, there was an imminent tightening of safe management measures for COVID-19, and hospitals were deferring elective surgeries, said Mr Lee's daughter. She asked why her father's surgery proceeded during the ongoing pandemic at the time. She also asked if the respiratory arrest was preventable. THE DOCTOR'S RESPONSE On the timing of the procedure, Dr Tan said Mr Lee was concerned that his condition might deteriorate as his father's had and did not want to delay it. Dr Tan said he had "thoroughly explained" the risks and benefits of the spinal surgery, and had taken the general precautions during the operation. He said the medical staff were not sure what caused Mr Lee's respiratory arrest at the time, and that the priority was to intubate him, but the first attempts were unsuccessful. About 10 to 15 minutes passed between his respiratory arrest and his intubation, and it was this prolonged downtime that resulted in Mr Lee's brain injury, said Dr Tan. He said the existence of a blood clot at the surgical site was discovered only after the MRI done two days after the surgery. ON THE COVID-19 JAB Dr Tan testified that he was aware that Mr Lee had the COVID-19 jab 10 days prior to the surgery. He said Mr Lee had fully recovered from the vaccination and had "no abnormal symptoms" which could be attributed to the vaccine. In addition, he had been determined to be fit for the surgery by the cardiologist and anaesthetist. He said Mr Lee's collapse was "very sudden", his blood pressure had spiked, and his oxygen saturation came down "all within a couple of minutes". Dr Teo, who had conducted the autopsy, said "there was no reason to delay surgery after a patient receives COVID-19 vaccination". "In fact, an unvaccinated patient entering a hospital environment would be at a higher risk of contracting a COVID-19 infection," he said. He added that patients who developed COVID-19 infections after surgery were at risk of slower recovery or an adverse outcome, especially if they had other chronic medical conditions. He said there was in fact an increased risk of post-surgical mortality related to the COVID-19 infection. Dr Teo said there was no autopsy evidence that the vaccine had caused or contributed to Mr Lee's death. He also noted that there was no indication in any of the medical reports that the medical staff was concerned that the vaccine was related to the cause of death. ON WHY THE ELECTIVE SURGERY WAS DONE The director of operations for Mount Elizabeth Hospital, Dr Ng Shang Qun Shawn, noted that there were two policies issued by the Ministry of Health at the time Mr Lee's surgery was performed. One circular stated that healthcare resources were tight and should be prioritised according to medical needs and urgency. Another stated that public healthcare institutions had been informed to start triaging and deferring non-urgent surgery and admission as well as non-urgent specialist outpatient clinic appointments from May 3, 2021. However, Dr Ng explained that private hospitals like Mount Elizabeth Hospital were not mandated to defer non-urgent surgeries. The circular recommended that private hospitals defer non-urgent surgeries only "where possible so as to avail capacity, resources and manpower should they be needed to support the private sector". Therefore, based on the circulars, doctors at private hospitals would "make a call" and proceed on some elective surgeries based on available capacity and resources. In Mr Lee's case, the elective surgery had been allowed to proceed as the doctors involved made the decision that it could. Mr Tan said Mr Lee had been counselled on the risks and benefits of the surgery, the alternative surgical options and the option for conservative treatment. The coroner found the consent form for the procedure was "a very comprehensive" one, and there was no evidence to suggest that the risks were not highlighted to Mr Lee. Mr Lee had accepted them of his own accord and opted for the procedure, said the coroner. He added that there was no evidence to suggest that having a COVID-19 jab made him unsuitable for the procedure.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store